You are here

InventisBio

Few signs of gout pipeline flaring up

EP Vantage

Thu, 05/18/23 - 10:45 am

Selecta Biosciences

Arthrosi Therapeutics

Atom Bioscience

Dyve Biosciences

Hinova Pharmaceuticals

Horizon Therapeutics

Jiangsu Hengrui Pharmaceuticals

Olatec Therapeutics

Shanton Bioscience

InventisBio reels in $147M to push gout and breast cancer drugs along

Endpoints

Mon, 09/28/20 - 10:42 am

Clinical stage biotech company InventisBio closes $70m Series C financing

Pharmaceutical Business Review

Tue, 03/12/19 - 11:35 am

estrogen-receptor cancer